Principles Of Hiv Prevention In Drug Using Populations

The National Institute on Drug Abuse (NIDA) has sponsored a comprehensive research program in response to the dynamic nature of the co-occurring epidemics of drug abuse and HIV/AIDS. This research has yielded a set of scientifically based principles for the use of community planners, policymakers, service providers, and medical practitioners as they develop and implement programs to prevent the spread of HIV and other infections among injecting and non-injecting drug users and their sexual partners.

This research-based guide will help to foster the scientifically based principles yielded by the research of the co-occurring epidemics of drug abuse & HIV/AIDS. Summarizes the basic overarching principles that characterize effective HIV/AIDS prevention in drug-using populations. Elaborates on these principles by providing answers to frequently asked questions. Describes the epidemiology of HIV/AIDS risk behaviors. Provides an overview of major research programs since the mid-1980s to gauge the effectiveness of outreach-based interventions in preventing the spread of HIV/AIDS & other diseases among drug users & their sex partners.

AIDS, Drugs and Prevention brings together a range of international contributions on the research, theory and practice of developing community-based HIV prevention. It aims to understand how individual actions to prevent HIV transmission are constrained and encouraged by situational and social context. Drawing on ethnographic and epidemiological research among populations of drug users, sex workers and gay men, it explores how future HIV prevention interventions can target changes at the level of the individual as well as at the level of the community and wider social environment. AIDS, Drugs and Prevention offers practical and theoretical insights into community-based health work in the time of AIDS. It provides invaluable reading for students, lecturers, researchers and practioners in health promotion, health policy, social work and medical sociology.

HIV/AIDS continues to be the pandemic of our times and there has not been a comprehensive medically based AIDS prevention book published in the last 5 years. It is estimated that 36 to 45 million people including 2-3 million children already are infected worldwide and an additional 4-7 million more are infected each year. There are about 6,000 new infections daily and about 12 million AIDS orphans. People receiving AIDS treatments feel well and have no detectable viral load, but still can infect others. And even when a vaccine is found, it will take many years before it can be administered across the developing world. * Discusses all aspects of AIDS prevention, from epidemiology, molecular immunology and virology to the principles of broad-based public health prevention interventions. * Special focus on the array of interventions that have been proven effective through rigorous study * Identifies new trends in HIV/AID epidemiology and their impact on creating and implementing prevention interventions * Incorporates virology, biology, infectious diseases, vaccinology, microbicides and research methodologies into AIDS prevention

"Brings together leading and emerging researchers to advance understanding of the complex relationships between homelessness and health. Covering a wide range of topics from youth homelessness to end-of-life care, contributors outline policy and practice recommendations to respond to this public health crisis."--Back cover.

Proceedings of a workshop held to contribute to the prevention of HIV infection and its consequences by highlighting new information and strategies to reduce HIV transmission associated with the use of alcohol and other drugs, both licit and illicit. Topics of papers include the extent of HIV infection and drug use in Canada; contextual and community considerations in HIV, sexual behaviour, and substance use research; risk taking contexts among addicts; HIV infection prevention measures; issues and challenges in the management of HIV prevention; criminal law and drugs; drug policy and law enforcement; prevalence, incidence, and risk factors of HIV for injection drug users; targeting vulnerable populations such as women, youth, and gays; and perspectives on HIV prevention from Canada, the United States, and Britain. Appendices include an outline of issues and recommendations from working sessions.